Cross‐talk of alpha tocopherol‐associated protein and JNK controls the oxidative stress‐induced apoptosis in prostate cancer cells. Issue 10 (28th November 2012)
- Record Type:
- Journal Article
- Title:
- Cross‐talk of alpha tocopherol‐associated protein and JNK controls the oxidative stress‐induced apoptosis in prostate cancer cells. Issue 10 (28th November 2012)
- Main Title:
- Cross‐talk of alpha tocopherol‐associated protein and JNK controls the oxidative stress‐induced apoptosis in prostate cancer cells
- Authors:
- Zhu, Baoyi
Li, Xiaojuan
Zhang, Yuying
Ye, Chunwei
Wang, Yu
Cai, Songwang
Huang, Huaiqiu
Cai, Yi
Yeh, Shuyuan
Huang, Zhenhua
Chen, Ruihan
Tao, Yiran
Wen, Xingqiao - Abstract:
- <abstract abstract-type="main" xml:lang="en"> <title>Abstract</title> <p>Excess intracellular reactive oxygen species (ROS) beyond a threshold can induce apoptosis in cancer cells. However, the signal pathways that can augment the proapoptotic function of ROS remain largely unknown. We previously identified a tumor suppressor, alpha‐tocopherol‐associated protein (TAP), yet little is known regarding the role of TAP in the apoptotic signaling in prostate cancer. Interestingly, we recently found that exposure of prostate cancer cells to hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>) resulted in induced apoptosis as well as increased expression of TAP. Small interfering RNA (siRNA) mediated silencing of endogenous TAP expression conferred effective protection from H<sub>2</sub>O<sub>2</sub>‐induced apoptosis. Further mechanistic study showed exposure of prostate cancer cells to H<sub>2</sub>O<sub>2</sub> resulted in increased phosphorylation of both JNK and c‐Jun, and TAP siRNA effectively decreased H<sub>2</sub>O<sub>2</sub>‐induced JNK and c‐Jun phosphorylation. Immunoprecipitation experiments revealed that JNK physically associates with TAP. Furthermore, signaling downstream of JNK to the AP‐1 complex and BH‐3‐only subfamily were found to be regulated on changing the TAP expression status. TAP could also promote the oxidative stress‐induced apoptosis effect of docetaxel. In the mice xenograft model, H<sub>2</sub>O<sub>2</sub> treatment induced TAP expression, JNK<abstract abstract-type="main" xml:lang="en"> <title>Abstract</title> <p>Excess intracellular reactive oxygen species (ROS) beyond a threshold can induce apoptosis in cancer cells. However, the signal pathways that can augment the proapoptotic function of ROS remain largely unknown. We previously identified a tumor suppressor, alpha‐tocopherol‐associated protein (TAP), yet little is known regarding the role of TAP in the apoptotic signaling in prostate cancer. Interestingly, we recently found that exposure of prostate cancer cells to hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>) resulted in induced apoptosis as well as increased expression of TAP. Small interfering RNA (siRNA) mediated silencing of endogenous TAP expression conferred effective protection from H<sub>2</sub>O<sub>2</sub>‐induced apoptosis. Further mechanistic study showed exposure of prostate cancer cells to H<sub>2</sub>O<sub>2</sub> resulted in increased phosphorylation of both JNK and c‐Jun, and TAP siRNA effectively decreased H<sub>2</sub>O<sub>2</sub>‐induced JNK and c‐Jun phosphorylation. Immunoprecipitation experiments revealed that JNK physically associates with TAP. Furthermore, signaling downstream of JNK to the AP‐1 complex and BH‐3‐only subfamily were found to be regulated on changing the TAP expression status. TAP could also promote the oxidative stress‐induced apoptosis effect of docetaxel. In the mice xenograft model, H<sub>2</sub>O<sub>2</sub> treatment induced TAP expression, JNK phosphorylation and apoptosis of prostate cancer. Recombinant adeno‐associated virus 2 (rAAV2)‐TAP injection significantly sensitizes this H<sub>2</sub>O<sub>2</sub> proapoptotic effect. Together, we have identified a novel functional mechanism that the cross‐talk of TAP‐JNK is involved in oxidative stress‐induced apoptosis in prostate cancer cells. Disrupting the redox balance of cancer cells by this signaling may enable therapeutic selectivity and provide benefit to overcome the drug resistance of prostate cancer.</p> </abstract> … (more)
- Is Part Of:
- International journal of cancer. Volume 132:Issue 10(2013:May 15)
- Journal:
- International journal of cancer
- Issue:
- Volume 132:Issue 10(2013:May 15)
- Issue Display:
- Volume 132, Issue 10 (2013)
- Year:
- 2013
- Volume:
- 132
- Issue:
- 10
- Issue Sort Value:
- 2013-0132-0010-0000
- Page Start:
- 2270
- Page End:
- 2282
- Publication Date:
- 2012-11-28
- Subjects:
- Cancer -- Periodicals
Cancer -- Prevention -- Periodicals
616.994 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1097-0215 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/ijc.27927 ↗
- Languages:
- English
- ISSNs:
- 0020-7136
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4542.156000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 4198.xml